Conference paper

Hormonal therapy in systemic lupus erythematosus

Dušanka Martinović Kaliterna ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Split, Split, Croatia
Danijela Marasović Krstulović ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Split, Split, Croatia
Mislav Radić ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Split, Split, Croatia

Abstract

Estrogens favor the development and/or exacerbation of systemic lupus erythematosus (SLE). Numerous reports have described the association between estrogens exposure (oral contraceptives and menopause hormonal therapy) and development or exacerbation of SLE. Some new studies showed benefit from oral contraceptives and other hormonal therapies without a change in lupus activity but with increased risk of thrombosis. Hormonal therapy in SLE patients should be individual according to clinical presentation and progression of the disease.

Keywords

systemic lupus erythematosus; hormonal therapy; estrogens; menopause

Hrčak ID:

125192

URI

https://hrcak.srce.hr/125192

Publication date:

21.11.2009.

Article data in other languages: croatian

Visits: 1.195 *